Iterion Therapeutics (Series B)
Funding Details
- Awarder
- Inbox
- Date Award
- February 16, 2021
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $17,000,000
Company Info
- Founders
- Rahul Aras, Ph.D.
- Company Description
- Iterion Therapeutics is a venture-backed, clinical-stage biotechnology company that develops novel targeted cancer therapeutics.
- Market
- Cancer therapeutics
- Location
- Houston, Texas, USA
- Coinvestors
- GPG Ventures, Lumira Ventures, Sante Ventures, Venture Investors, Viva BioInnovator